Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...
Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...
News Medical on MSN7d
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domainAnnouncing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...
The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...
Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ...
Disinfecting surfaces is crucial in keeping bacteria and viruses at bay, but the cleaning solutions could be ineffective if ...
Researchers developed a model that detects SARS-CoV-2 mutations linked to increased transmission, identifying high-risk ...
IFLScience on MSN8d
Nanoparticle Vaccine Could Protect Against Future COVID-19 Variants – Plus Other CoronavirusesA newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...
The following is a summary of “Plasma Lipopolysaccharide-Binding Protein (LBP) Is Induced in Critically Ill Females with Gram ...
Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...
Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...
“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback